{
 "generic_name": "Iron Sucrose Injection",
 "slug": "iron-sucrose-injection",
 "brand_names": [
  "Iron Sucrose"
 ],
 "fda_status": [
  "To Be Discontinued"
 ],
 "last_fda_update": "05/21/2026",
 "first_posted": "05/21/2026",
 "synced_at": "2026-10-01T04:04:04.751Z",
 "presentations": [
  {
   "company": "Mylan Institutional, a Viatris Company",
   "package_ndc": "67457-957-99",
   "presentation": "Iron Sucrose, Injection, 50 mg/2.5 mL (NDC 67457-957-99)",
   "availability": "Not specified",
   "availability_raw": null,
   "fda_note": "A business decision has been made to discontinue of 2.5mL presentation only. Continuity of supply is forecasted across all other presentations of Iron Sucrose: 67457-639-10 Iron Sucrose 20mg/mL 10mL SDV 5PK 67457-638-10 Iron Sucrose 20mg/mL 5mL SDV 10PK 67457-638-25 Iron Sucrose 20mg/mL 5mL SDV 25PK."
  }
 ],
 "changes": []
}